Project Grant R44MH129278

Award Date 9/20/21
Completion Date 8/31/24
Dollars Obligated $7.6M
Funding Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Sebastopol, CA 95472, USA
Similar Awards
The National Institute of Biomedical Imaging and Bioengineering (NIBIB), through its Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded a $412,801 Project Grant (R01EB035091) to Brigham & Women's Hospital Inc. in Boston, MA to develop an abbreviated, yet enhanced, brain MRI protocol. The goal is to significantly reduce MRI exam duration (from 20-30 minutes to 8 minutes) while capturing quantitative and qualitative MRI...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $390,616 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the Regents of the University of Michigan for the development of layer-specific functional magnetic resonance imaging (fMRI) techniques for clinical 3 Tesla scanners. The goal is to improve signal-to-noise ratio and reduce scan time for layer-specific fMRI, which currently...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) provides $185,625 to The General Hospital Corporation (Massachusetts General Hospital) to develop a novel magnetic resonance imaging (MRI) technology. The project aims to address the challenge of flip angle inhomogeneity in high-field 7 Tesla MRI systems by introducing a...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $1,372,638 to Yale University to develop and evaluate a parallel acquisition system for magnetic resonance imaging (MRI) and deuterium metabolic imaging (DMI). The goal is to create a robust, time-efficient method to acquire both anatomical MRI and non-invasive...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $1,336,000.00 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop rapid, motion-robust, and low-gadolinium MRI techniques for improved diagnosis and monitoring of pediatric brain tumors. The key objectives are to:...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $534,141 to Boston Children's Hospital to develop and evaluate advanced functional MRI (fMRI) acquisition methods for pre-surgical mapping in pediatric epilepsy patients. The key objectives are to: 1) Develop a novel technology using free induction decay (FID) navigators to measure...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop a rapid, distortion-free, and motion-robust technique for submillimeter-resolution T2* and quantitative susceptibility mapping (QSM) of the human brain. The $103,441 award, valid from August 1, 2024 to July 31, 2026, will fund research at Stanford University to...
This federal Project Grant award, worth $621,617, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award supports the development and optimization of a rapid and robust quantitative magnetic resonance (MR) imaging technique for high-resolution volumetric brain imaging. Key objectives include: Developing and optimizing a new B1-insensitive MR...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $497,196 to The Johns Hopkins University to develop and evaluate a new pulse sequence for simultaneous downfield (DF) and upfield (UF) proton magnetic resonance spectroscopic imaging (MRSI) at 3T. The goals include improving the sensitivity and excitation profiles...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $306,203 to Resonance Research Inc. to develop an optimized prototype of a digitally-controlled, real-time multiband shimming system for improved neuroimaging on Siemens 7T MRI scanners. The goal is to demonstrate the feasibility of a practical shim subsystem that can...

HIGHLY EFFICIENT MRI PULSE SEQUENCES FOR HIGH RESOLUTION PHYSIOLOGICAL AND FUNCTIONAL BRAIN IMAGING - SUMMARY THIS PROJECT WILL DEVELOP MRI PHYSIOLOGICAL IMAGING WITH HIGHER SPATIAL AND TEMPORAL RESOLUTION, LARGER BRAIN COVERAGE, AND FASTER ACCELERATED PULSE SEQUENCES. THE PHYSIOLOGIC IMAGES HAVE CONTRASTS OF MICROVASCULAR- WEIGHTED BLOOD OXYGEN LEVEL DEPENDENT (BOLD), CEREBRAL BLOOD FLOW (CBF) AND CEREBRAL BLOOD VOLUME (CBV). IMPORTANTLY, THE TECHNIQUES TO BE DEVELOPED ARE LARGELY INSENSITIVE TO VENOUS BLOOD CONTRIBUTIONS TO SIGNAL, UNLIKE TRADITIONAL BOLD ECHO PLANAR IMAGING (EPI) SEQUENCES, AND THUS THEY ARE EXTREMELY USEFUL FOR PRECISION IMAGING OF PHYSIOLOGICAL MARKERS IN NEUROLOGICAL DISORDERS AND FOR HIGHER SPECIFICITY IN CORTICAL LAYER FMRI, ENABLING HIGHER GRANULARITY IN HUMAN NEUROCIRCUITRY IMAGING. NOVEL ACCELERATION TECHNIQUES FOR EACH PULSE SEQUENCE WILL BE INCORPORATED TO INCREASE SLICE-VOLUME COVERAGE AND IMPROVE SIGNAL TO NOISE RATIO (SNR) AND POINT SPREAD FUNCTION (PSF) IN SIGNAL LOCALIZATION. SEQUENCE DEVELOPMENT AND EVALUATIONS WILL BE PERFORMED AT SEVERAL 3T AND 7T IMAGING SITES. WE WILL DEVELOP A SOFTWARE PACKAGE WITH ADVANCED VARIANTS OF SEVERAL PULSE SEQUENCES: ZOOMED 3D GRADIENT-AND-SPIN-ECHO (GRASE), ARTERIAL SPIN LABELING (ASL) FOR CBF IMAGING, SLICE- SATURATION SLAB- INVERSION VASCULAR SPACE OCCUPANCY (SS-SI-VASO) FOR CBV IMAGING, AND THE NOVEL VASO TECHNIQUE WITH "MULTIPLE ACQUISITIONS WITH GLOBAL EXCITATION CYCLING" (MAGEC)-VASO TO ACHIEVE WHOLE BRAIN COVERAGE. THE SOFTWARE PACKAGE WILL ALSO INCLUDE A MODULAR ANALYSIS PIPELINE FOR USE BY NEUROSCIENTISTS AND PHYSICIANS WITHOUT THE NEED FOR EXTENSIVE MR-PHYSICS OR CODING EXPERTISE. ACHIEVING NON-INVASIVE IMAGING OF NEURONAL CIRCUITS IN THE HUMAN BRAIN WILL ALLOW NEUROSCIENTISTS TO STUDY NORMAL BRAIN PROCESSES AND ALLOW MEDICAL SCIENTISTS TO STUDY NEUROCIRCUITRY CHANGES AND NEUROLOGICAL DISEASES. CURRENTLY, HIGH-RESOLUTION FMRI TECHNOLOGY COULD BE USED TO IDENTIFY FMRI OF NEURAL ACTIVITY AT DIFFERENT CORTICAL DEPTHS, BUT IS SEVERELY LIMITED BY POORLY LOCALIZED SIGNAL FROM VENOUS DRAINAGE IN THE CORTEX. THIS PROJECT INNOVATES NEW, ROBUST 3D FMRI IMAGING SEQUENCES THAT ELIMINATE VENOUS CONTAMINATION, THUS AFFORDING HIGH FIDELITY MAPPING OF FINE-SCALE NEURONAL CIRCUITRY COMPARED TO CURRENT GRADIENT ECHO EPI BOLD IMAGING.

Posted 9/20/21, 12:00 AM